Exclusive: Siduma, a biotech from Arvinas’ scientific founder, shutters due to ‘financing environment’
Siduma Therapeutics, a Yale spinout from Arvinas scientific founder Craig Crews, has closed, a spokesperson for the company confirmed to Endpoints News via email Thursday. “In response to the challenging funding environment for early-stage science, Siduma Therapeutics’ leadership has made the difficult decision to suspend operations and return investment back